经动脉化疗栓塞术作为超巨大肝血管瘤的主要治疗方法。
Transarterial chemoembolization as the primary treatment for a super-giant hepatic hemangioma.
作者信息
Bolger Kevin, Choudhary Moaz M, Kouri Brian
机构信息
Department of Interventional Radiology, Atrium Health Wake Forest Baptist, Wake Forest University School of Medicine, 1 Medical Center Blvd, Winston-Salem, NC 27157, USA.
出版信息
Radiol Case Rep. 2022 Oct 28;18(1):94-96. doi: 10.1016/j.radcr.2022.09.095. eCollection 2023 Jan.
Hepatic hemangiomas are common benign liver tumors. While the majority are small and require no treatment, giant hemangiomas are characterized as measuring greater than 4-6 cm in size and may require intervention. Surgical resection and enucleation have been described historically as the treatment for giant hemangiomas requiring intervention. Additionally, limited data exists about the treatment of hemangiomas measuring greater than 20 cm, particularly in regards to transarterial chemoembolization. We present a case of a super-giant hemangioma measuring greater than 20 cm treated with transarterial chemoembolization alone.
肝血管瘤是常见的肝脏良性肿瘤。虽然大多数肝血管瘤较小，无需治疗，但巨大肝血管瘤的特征是直径大于4 - 6厘米，可能需要干预。历史上，手术切除和摘除术一直被描述为治疗需要干预的巨大肝血管瘤的方法。此外，关于直径大于20厘米的肝血管瘤的治疗，特别是经动脉化疗栓塞方面的数据有限。我们报告一例仅接受经动脉化疗栓塞治疗的直径大于20厘米的超大肝血管瘤病例。
Zotero 插件